Search by Drug Name or NDC

    NDC 51655-0783-52 Levothyroxine sodium 150 ug/1 Details

    Levothyroxine sodium 150 ug/1

    Levothyroxine sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 51655-0783
    Product ID 51655-783_da8280de-18c0-40c0-e053-2a95a90a1eb3
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Levothyroxine sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levothyroxine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units ug/1
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name Northwind Pharmaceuticals
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212399
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0783-52 (51655078352)

    NDC Package Code 51655-783-52
    Billing NDC 51655078352
    Package 30 TABLET in 1 BOTTLE, PLASTIC (51655-783-52)
    Marketing Start Date 2021-08-12
    NDC Exclude Flag N
    Pricing Information N/A